The PERSEVERE Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT06588634

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
  • Inari Medical Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06588634
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, France, Germany, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06588634. Randomized; no masking; primary purpose treatment. Start 2024-12-16 (actual); primary completion 2027-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The PERSEVERE Study
Condition
Pulmonary Thromboembolism
Intervention (Device)
FlowTriever System
Intervention (Procedure)
Standard of Care
Lead sponsor
Inari Medical (class: industry)

Record details

Record id
cardio:ct-nct06588634
Content hash
035cba0e7f70079038c1916d4d161440097531df16964a70d6397794147b83ee